DermEffects: Dr. Wei Jing Loo
1560 Hyde Park Road
London, ON N6H 5L5
(519) 472-8686 (Cosmetic Inquiries)
(519) 472-2929 (Medical Inquiries)
(519) 472-8484 (Fax)
Monday–Friday: 7 a.m.–3 p.m.

Comparator Trial for Plaque Psoriasis (68 Weeks)

Adults aged 18-75 years old with stable moderate to severe plaque psoriasis for at least 6 months, may qualify to participate. Individuals must have psoriatic involvement of 10% or more body surface area. Previous failure, inadequate response, intolerance, or contraindication to at least 1 conventional anti-psoriatic systemic therapy is required. There must also be no known history of latent or active tuberculosis (TB); testing will occur at screening.

Participants will be part of one of two groups: the continued-use group (receiving ustekinumab) OR the switching group (receiving investigational medication (active study drug) and ustekinumab), via subcutaneous injection. Study medication and study-related assessments will be provided at no cost. Reimbursement for study-related expenses will also be provided.

Study participation will last about 68 weeks and involve about 14 visits to the study centre.